2 completed, 1 not yet recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Trifluridine and Tipiracil Tablets: new trials by email Literature Review of Trifluridine and Tipiracil Tablets trials Research Report on Trifluridine and Tipiracil Tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SBRT Followed by PD-1 Inhibitor, Bevacizumab and TAS-102 as Third-Line Therapy for Recurrent/Metastatic Colorectal Cancer SBRT, Sintilimab, Bevacizumab - Colorectal Neoplasms | Phase 2 | Not yet recruiting | Shanghai Zhongshan Hospital | 58 | 2026-06-01 | 2026-04-17 |
| Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans Trifluridine and Tipiracil Tablets, Lonsurf® - Solid Tumor Cancer | Not applicable | Completed | Shandong New Time Pharmaceutical Co., LTD | 76 | 2022-11-21 | 2026-03-25 |
| Bioequivalence Study of Trifluridine and Tipiracil Tablets in Colorectal Cancer Patients Trifluridine and Tipiracil Tablets, TAS-102 - Colorectal Cancer | Phase 1 | Completed | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 64 | 2019-05-21 | 2022-04-19 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Shandong New Time Pharmaceutical Co., LTD (1) · Shanghai Zhongshan Hospital (1)
China (3)